Cyclin E2 antibody (AA 255-404)
Quick Overview for Cyclin E2 antibody (AA 255-404) (ABIN7153399)
Target
See all Cyclin E2 (CCNE2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Binding Specificity
- AA 255-404
- 
                                            Cross-Reactivity
- Human
- 
                                            Purification
- Antigen Affinity Purified
- 
                                            Immunogen
- Recombinant Human G1/S-specific cyclin-E2 protein (255-404AA)
- 
                                            Isotype
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- 
                                            Preservative
- Sodium azide
- 
                                            Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Storage
- -20 °C,-80 °C
- 
                                            Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - Cyclin E2 (CCNE2)
- 
                                            Alternative Name
- CCNE2
- 
                                            Background
- 
                        Background: Essential for the control of the cell cycle at the late G1 and early S phase. Aliases: CCNE2 antibody, G1/S-specific cyclin-E2 antibody 
- 
                                            UniProt
- O96020
- 
                                            Pathways
- Cell Division Cycle, Mitotic G1-G1/S Phases
 Target
- 
                    
 
                                     
                                     
                                    